Open Orphan is rapidly developing into a leading European rare disease and orphan drug focused pharma services company. Venn Life Sciences – part of the Open Orphan plc family: Read More

Your Partners for Drug and Medical Device Development

European Focus – International Coverage

Venn Life Sciences is an Integrated Drug Development Partner offering a unique combination of pre-clinical and CMC drug development expertise, clinical trial design and management. This enables us to create, plan and execute drug and medical device development programs effectively and seamlessly for our clients.

CLIENT TESTIMONIAL
“We have been delighted to work with Venn Life Sciences on this complex clinical trial. Their commitment to quality coupled with an in-depth knowledge of running Investigator Initiated Studies has facilitated the effective and efficient management of the various activities and requirements associated with the study. We fully expect that together we will bring the trial to completion on time and on budget.”
Professor Keith G. Oldroyd, Director of Research and Development West of Scotland Regional Heart & Lung Centre, Golden Jubilee National Hospital
NEWS & EVENTS
22May

Results of Fundraising

0 Comments
(“Open Orphan”, the “Company” or the “Group”) Results of Fundraising 22 May 2020 Open Orphan plc (ORPH), a rapidly growing... Read More →
22May

New COVID-19 Antibody Testing Partnership

0 Comments
Open Orphan plc (“Open Orphan” or the “Company”) New COVID-19 Antibody Testing Partnership Quotient Limited and hVIVO Announce Partnership to... Read More →
05May

Major New Contract and Directorate Change

0 Comments
Open Orphan plc (“Open Orphan” or the “Company”) Major New Contract and Directorate Change New contract signed with US Biotechnology... Read More →
CONTACT US

No Events on The List at This Time

Above are the current and upcoming events for the year that you will find Venn Life Sciences attending. Click to view the Events Calender.
Back to Top
X